Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scpharmaceuticals Inc.

2.32
-0.1600-6.45%
Post-market: 2.320.00000.00%19:01 EDT
Volume:399.57K
Turnover:938.00K
Market Cap:116.66M
PE:-1.21
High:2.48
Open:2.48
Low:2.29
Close:2.48
Loading ...
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 29, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 20, 2024

Correspondence

Form CORRESP - Correspondence
Mar 13, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 13, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]